Background
Verified Service Provider in Congo (Brazzaville)

Molecular Diagnostics Labs in Congo (Brazzaville) Engineering Excellence & Technical Support

Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.

Talk To Sales

Advanced PCR & Gene Sequencing Capabilities

Our state-of-the-art molecular diagnostics laboratory in Brazzaville is equipped with cutting-edge Polymerase Chain Reaction (PCR) and next-generation sequencing (NGS) technologies. This enables rapid and highly accurate detection of infectious diseases, genetic disorders, and provides critical data for personalized medicine initiatives across the Republic of Congo.

Real-time Diagnostic Assay Development

We specialize in the rapid development and validation of real-time diagnostic assays tailored to the specific health challenges of Congo. Our expertise in molecular biology allows us to create sensitive and specific tests for emerging pathogens and endemic diseases, ensuring timely and effective public health responses.

Genomic Surveillance & Outbreak Intelligence

Leveraging our robust molecular diagnostic infrastructure, we are actively engaged in genomic surveillance programs. By analyzing pathogen genomes, we contribute to early outbreak detection, tracking transmission patterns, and informing public health strategies to combat infectious disease outbreaks within Congo and the wider region.

What Is Molecular Diagnostics Labs In Congo (Brazzaville)?

Molecular diagnostics laboratories in Congo (Brazzaville) represent specialized facilities equipped to perform tests that analyze the genetic material (DNA or RNA) of pathogens, individuals, or biological samples. These labs utilize advanced techniques such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and hybridization assays to detect and characterize specific nucleic acid sequences. The primary objective is to identify infectious agents with high sensitivity and specificity, assess genetic predispositions to diseases, monitor treatment efficacy, and support personalized medicine approaches. The establishment and operation of these laboratories are crucial for public health surveillance, clinical decision-making, and advancing biomedical research within the Republic of the Congo.

Who Needs Molecular Diagnostics?Typical Use CasesClinical Significance
Individuals with suspected infectious diseases: Experiencing symptoms suggestive of viral (e.g., influenza, COVID-19, HIV, hepatitis), bacterial (e.g., tuberculosis, meningitis), or parasitic (e.g., malaria) infections.Confirmation of diagnosis for infectious diseases: Providing definitive identification of causative agents, enabling targeted treatment and reducing empirical prescribing.Early and accurate diagnosis: Leading to timely initiation of appropriate therapy, improved patient outcomes, and reduced morbidity and mortality.
Patients undergoing treatment for chronic or infectious diseases: Requiring monitoring of disease progression, treatment response, or drug resistance.Monitoring of viral load: Particularly for conditions like HIV and hepatitis B/C, to assess the effectiveness of antiretroviral therapy (ART) or antiviral medications.Therapeutic drug monitoring and resistance detection: Guiding treatment adjustments to optimize efficacy and prevent the development of resistant strains.
Individuals with a family history of genetic disorders or at risk for hereditary conditions: To assess genetic predisposition.Genetic screening and risk assessment: Identifying individuals who may carry genes for inherited diseases such as sickle cell anemia, cystic fibrosis, or certain cancers.Informed genetic counseling and preventative strategies: Empowering individuals and families to make informed decisions about reproductive planning and risk management.
Public health agencies and disease surveillance programs: For epidemic preparedness, outbreak investigations, and pathogen surveillance.Pathogen surveillance and outbreak investigations: Identifying and tracking the spread of infectious diseases, including emerging and re-emerging pathogens, to inform public health interventions.Epidemiological monitoring and control: Facilitating the rapid containment of outbreaks and the development of effective public health strategies.
Oncologists and cancer patients: For cancer diagnosis, prognosis, and personalized treatment selection.Cancer molecular profiling and targeted therapy: Detecting specific genetic mutations in tumors to guide the selection of targeted therapies and immunotherapies.Personalized oncology: Tailoring cancer treatment to the molecular characteristics of an individual's tumor, improving treatment efficacy and reducing adverse effects.
Researchers in academia and industry: For studies on disease mechanisms, drug discovery, and development.Biomedical research and drug development: Investigating disease pathogenesis, identifying novel biomarkers, and evaluating the efficacy of new diagnostic and therapeutic agents.Advancement of scientific knowledge and innovation: Contributing to the development of new diagnostics, treatments, and public health solutions.

Key Aspects of Molecular Diagnostics Labs in Congo (Brazzaville):

  • Core Technology: Primarily employs nucleic acid amplification techniques (e.g., real-time PCR, digital PCR) and sequencing technologies (e.g., Sanger, NGS).
  • Sample Types: Analyzes a wide range of biological specimens including blood, saliva, urine, swabs (nasopharyngeal, oropharyngeal), tissue biopsies, and cerebrospinal fluid.
  • Diagnostic Scope: Capable of identifying viral, bacterial, parasitic, and fungal pathogens; detecting genetic mutations associated with inherited diseases and cancer; and quantifying viral load for therapeutic monitoring.
  • Quality Control: Adheres to stringent quality assurance and quality control (QA/QC) protocols to ensure the accuracy, reliability, and reproducibility of test results. This includes validation of reagents, equipment calibration, and proficiency testing.
  • Infrastructure: Requires specialized equipment such as thermal cyclers, sequencers, automated nucleic acid extraction systems, biosafety cabinets (BSCs), and a robust laboratory information management system (LIMS).
  • Personnel: Staffed by highly trained molecular biologists, medical laboratory scientists, technicians, and bioinformaticians with expertise in molecular techniques and data interpretation.

Who Needs Molecular Diagnostics Labs In Congo (Brazzaville)?

Molecular diagnostics laboratories in Congo (Brazzaville) are essential for advancing healthcare and public health initiatives. They provide precise and rapid identification of diseases, enabling targeted treatments and effective outbreak control. These advanced facilities are crucial for diagnosing infectious diseases, genetic disorders, and cancers, ultimately improving patient outcomes and contributing to a stronger public health infrastructure.

Customer/DepartmentKey Needs/Services RequiredImpact of Molecular Diagnostics
Infectious Disease DepartmentsRapid and accurate diagnosis of viral (e.g., HIV, Hepatitis, Ebola, COVID-19), bacterial (e.g., Tuberculosis, Malaria), and parasitic infections; antimicrobial resistance testing.Enables prompt treatment initiation, reduces transmission rates, supports outbreak surveillance and containment, and guides effective drug therapy.
Oncology DepartmentsTumor profiling for personalized cancer treatment (e.g., identifying driver mutations for targeted therapies), minimal residual disease monitoring, and early cancer detection.Improves treatment efficacy, reduces side effects, enhances patient survival rates, and allows for earlier intervention.
Maternal and Child Health DepartmentsScreening for congenital infections in pregnant women (e.g., TORCH infections), prenatal diagnosis of genetic disorders, and identification of pathogens in neonates.Prevents mother-to-child transmission of infections, allows for timely management of fetal and neonatal conditions, and reduces birth defects and infant mortality.
Genetics and Inherited Disease ClinicsDiagnosis of inherited genetic disorders (e.g., sickle cell disease, cystic fibrosis), carrier screening, and genetic counseling.Provides definitive diagnoses for patients and families, enables informed family planning, and facilitates personalized care for chronic conditions.
Public Health LaboratoriesEpidemiological surveillance, outbreak investigation, confirmation of laboratory results from peripheral sites, and monitoring of vaccine efficacy.Strengthens national disease surveillance systems, supports rapid public health response to epidemics, and informs public health policy.
Research and Academic InstitutionsDisease mechanism studies, development of new diagnostic tools, drug discovery, and training of future healthcare professionals.Drives innovation in healthcare, contributes to the understanding of local disease burdens, and builds local capacity for advanced medical research.
Blood Banks and Transfusion ServicesScreening of donated blood for infectious agents (e.g., HIV, Hepatitis B and C, Syphilis).Ensures the safety of the blood supply, preventing transfusion-transmitted infections.
Emergency and Trauma CentersRapid identification of life-threatening infections in critically ill patients.Facilitates immediate and appropriate treatment, improving survival rates in critical care settings.

Target Customers and Departments for Molecular Diagnostics Labs in Congo (Brazzaville)

  • Hospitals (Public and Private)
  • Clinics and Health Centers
  • Research Institutions and Universities
  • Public Health Agencies and Ministries of Health
  • Non-Governmental Organizations (NGOs) focused on health
  • International Health Organizations (e.g., WHO, CDC)

Molecular Diagnostics Labs Process In Congo (Brazzaville)

Molecular diagnostics laboratories in Congo (Brazzaville) play a crucial role in identifying infectious diseases, genetic disorders, and other conditions at the molecular level. The workflow, from initial inquiry to the final execution of a test, involves a series of carefully managed steps to ensure accuracy, efficiency, and timely results. This process is vital for public health surveillance, clinical decision-making, and research.

StageDescriptionKey ActivitiesPersonnel InvolvedEquipment/Materials
Inquiry and Sample ReceptionThe initial stage where a request for a molecular diagnostic test is made and the biological sample is received by the laboratory.Receiving the request form, verifying patient information, logging the sample into the laboratory information system (LIS), checking sample integrity and suitability for testing.Laboratory Technicians, Receptionists, Nurses (for sample collection).Request forms, LIS, sample collection kits, cool boxes, biohazard bags, specimen labels.
Sample Pre-processingPreparation of the biological sample for nucleic acid extraction.Centrifugation, aliquoting, dilution, inactivation (if necessary).Laboratory Technicians.Centrifuge, pipettes, microcentrifuge tubes, sterile consumables, biosafety cabinets.
Nucleic Acid ExtractionIsolation of DNA or RNA from the biological sample.Using commercial kits or in-house protocols to separate nucleic acids from cellular debris and other inhibitors.Laboratory Technicians, Molecular Biologists.DNA/RNA extraction kits (e.g., silica-based columns, magnetic beads), lysis buffers, wash buffers, elution buffers, vortex mixer, centrifuge, pipettes.
Amplification and DetectionTargeted amplification of specific DNA or RNA sequences and subsequent detection of the amplified product.Performing Polymerase Chain Reaction (PCR) or Reverse Transcription PCR (RT-PCR) using specific primers and probes, followed by detection methods like real-time fluorescence or gel electrophoresis.Molecular Biologists, Laboratory Technicians.PCR/RT-PCR machines (thermocyclers), master mixes (containing enzymes, nucleotides, buffers), primers, probes, RNA extraction kits (for RT-PCR), gel electrophoresis equipment (optional), fluorescent detectors.
Data Analysis and InterpretationAnalyzing the raw data generated by the detection system and interpreting the results in a clinical context.Reviewing amplification curves, determining Ct values (for real-time PCR), comparing to positive and negative controls, identifying presence or absence of the target analyte.Molecular Biologists, Pathologists, Clinical Scientists.Analysis software integrated with PCR machines, control samples, reference ranges, clinical guidelines.
Reporting and CommunicationCommunicating the final diagnostic report to the requesting clinician or healthcare facility.Generating a formal laboratory report, ensuring accuracy and completeness, discussing complex results with clinicians, maintaining patient confidentiality.Pathologists, Clinical Scientists, Laboratory Manager.Laboratory Information System (LIS), reporting templates, secure communication channels (fax, email, electronic health records).
Quality Assurance and ControlEnsuring the accuracy, reliability, and reproducibility of all laboratory procedures and results.Running positive and negative controls with each assay, participating in external quality assessment (EQA) programs, regular equipment maintenance and calibration, staff training.All Laboratory Personnel, Quality Manager.Control reagents, EQA samples, calibration standards, maintenance logs, training records, standard operating procedures (SOPs).

Molecular Diagnostics Lab Process in Congo (Brazzaville)

  • Inquiry and Sample Reception
  • Sample Pre-processing
  • Nucleic Acid Extraction
  • Amplification and Detection (e.g., PCR, RT-PCR)
  • Data Analysis and Interpretation
  • Reporting and Communication
  • Quality Assurance and Control

Molecular Diagnostics Labs Cost In Congo (Brazzaville)

Molecular diagnostics labs in Congo (Brazzaville) offer a range of services crucial for accurate disease identification and management. The cost of these tests is influenced by several factors, including the specific test required, the reagents and technology used, the laboratory's overhead, and the prevailing economic conditions in the country. Generally, more complex tests or those requiring specialized equipment and highly purified reagents will be more expensive. The exchange rate and inflation also play a significant role in the local currency pricing. While specific price lists are not readily available publicly, general price ranges can be estimated based on common molecular diagnostic procedures.

Molecular Diagnostic Test CategoryEstimated Price Range (CFA Francs)Notes
Basic Viral Load Testing (e.g., HIV, Hepatitis)35,000 - 70,000Commonly performed for monitoring chronic infections. Prices can vary based on viral load complexity and lab.
Bacterial Pathogen Identification (e.g., Tuberculosis, Sepsis)40,000 - 80,000Essential for targeted antibiotic treatment. May involve multiple targets.
Parasitic Disease Detection (e.g., Malaria, Leishmaniasis)30,000 - 60,000Important for prevalent tropical diseases. Can be multiplexed for several parasites.
Genetic Testing (e.g., Basic Genotyping)70,000 - 150,000+Includes screening for specific genetic predispositions or variations. Prices can escalate significantly for complex panels or sequencing.
COVID-19 PCR Testing25,000 - 45,000Price often dictated by government regulations or specific travel requirements. Can fluctuate.
Advanced Sequencing (e.g., Gene Sequencing)150,000 - 500,000+Used for in-depth genetic analysis, research, or rare disease diagnosis. Highly variable based on sequencing depth and gene targets.

Factors Influencing Molecular Diagnostics Lab Costs in Congo (Brazzaville)

  • Type of Test: PCR, sequencing, genetic analysis, etc.
  • Reagent and Kit Costs: Quality and specificity of diagnostic kits.
  • Technology and Equipment: Investment in advanced molecular biology equipment.
  • Laboratory Overhead: Staff salaries, facility maintenance, utilities.
  • Importation Costs: Duties and taxes on imported reagents and equipment.
  • Economical Conditions: Inflation, currency exchange rates, and local market demand.
  • Provider Type: Public vs. private laboratories, their pricing structures.
  • Volume of Tests: Bulk discounts may be available for higher volumes.

Affordable Molecular Diagnostics Labs Options

Affordable molecular diagnostics labs are increasingly crucial for accessible healthcare. These facilities leverage advanced technologies to identify genetic material (DNA/RNA) from pathogens, tumors, or individuals, enabling precise diagnosis, personalized treatment, and disease monitoring. The cost of these services can be a barrier for many, but several strategies and value propositions exist to make them more affordable. Understanding value bundles and implementing smart cost-saving measures are key to unlocking accessible molecular diagnostics.

Cost-Saving StrategyDescriptionImpact on Affordability
Bulk Purchasing & Volume DiscountsLabs negotiate lower prices for reagents and consumables by committing to high-volume purchases.Reduces per-test costs, making overall service prices more competitive.
Automation and High-Throughput PlatformsInvesting in automated systems for sample preparation and analysis increases efficiency and reduces labor costs.Lowers operational expenses, translating to more affordable testing.
Strategic Partnerships with Healthcare ProvidersCollaborating with hospitals and clinics to integrate diagnostics, potentially leading to streamlined workflows and shared resources.Can reduce overhead for both parties and offer bundled pricing for integrated care.
Focus on Specific Niche MarketsSpecializing in a particular area (e.g., rare genetic diseases) can allow for optimized workflows and expertise, leading to cost efficiencies.Enables focused investment in relevant technologies and reduces broad operational overhead.
Telehealth Integration for ConsultationsUsing telehealth for genetic counseling or follow-up consultations reduces the need for in-person visits, saving patients time and travel costs.Minimizes ancillary costs for patients and can be integrated into bundled service offerings.
Tiered Service OfferingsProviding different levels of testing or reporting based on clinical need and budget, from basic screening to comprehensive analysis.Offers flexibility for patients and providers to choose the most appropriate and affordable option.
Government and Non-Profit SubsidiesLeveraging grants or participating in programs that subsidize diagnostic testing for underserved populations.Directly reduces out-of-pocket costs for eligible individuals.

Understanding Value Bundles in Molecular Diagnostics

  • {"title":"What are Value Bundles?","description":"Value bundles are packages of multiple diagnostic tests or services offered together at a reduced price compared to purchasing each test individually. This can include a combination of genetic tests, pathogen identification panels, or biomarker assessments."}
  • {"title":"Benefits of Value Bundles","description":"Bundles simplify ordering, streamline interpretation, and offer significant cost savings, making comprehensive diagnostic approaches more financially viable for patients and healthcare providers."}
  • {"title":"Examples of Value Bundles","description":"Common bundles include: Comprehensive Cancer Panels (testing for multiple mutations in a tumor), Infectious Disease Panels (identifying a range of pathogens from a single sample), Pharmacogenomic Testing (predicting drug response based on genetics), and Prenatal Screening Bundles."}

Verified Providers In Congo (Brazzaville)

Finding reliable healthcare providers in Congo (Brazzaville) can be a challenge. Franance Health stands out as a premier choice due to its rigorous vetting process and commitment to quality. This document outlines the credentials that make Franance Health providers the best option for your healthcare needs in Congo (Brazzaville).

Provider TypeKey Franance Health VerificationBenefits to Patients
PhysiciansValid medical license, board certification (where applicable), verified educational background, criminal record check.Access to qualified doctors with proven expertise, reducing the risk of misdiagnosis or substandard treatment.
Specialists (e.g., Surgeons, Cardiologists)Advanced degree verification, specialized training certifications, peer references, documented successful procedures.Ensured access to highly specialized care for complex medical conditions.
Nurses and Allied Health ProfessionalsNursing council registration, relevant certifications (e.g., CPR, specialized nursing), background checks.Reliable support staff committed to patient well-being and care continuity.
Diagnostic LaboratoriesAccreditation by recognized bodies, quality control protocols, experienced technicians, compliance with safety standards.Accurate and timely diagnostic results you can trust.
PharmaciesPharmacy board licensing, verification of medication sourcing, adherence to dispensing regulations, qualified pharmacists.Access to legitimate and safe medications, dispensed by knowledgeable professionals.

Franance Health Credentials

  • Strict Licensing Verification: All healthcare professionals registered with Franance Health undergo thorough verification of their medical licenses and certifications with the relevant Congolese and international authorities.
  • Comprehensive Background Checks: Beyond professional qualifications, Franance Health conducts extensive background checks to ensure the integrity and trustworthiness of its providers.
  • Experience and Specialization Assessment: Providers are evaluated not only on their general medical expertise but also on their specific experience and specialization in relevant fields.
  • Commitment to Continuing Education: Franance Health prioritizes providers who demonstrate a dedication to ongoing professional development and staying abreast of the latest medical advancements.
  • Patient Feedback Integration: A system is in place to collect and review patient feedback, ensuring that providers maintain high standards of care and patient satisfaction.
  • Adherence to Ethical Standards: All Franance Health providers are expected to uphold the highest ethical principles in their practice.

Scope Of Work For Molecular Diagnostics Labs

This Scope of Work (SOW) outlines the technical deliverables and standard specifications for establishing and operating molecular diagnostics laboratories. It covers key aspects from infrastructure and equipment to testing methodologies, quality assurance, and reporting.

ParameterStandard SpecificationAcceptance Criteria
Biosafety LevelMinimum BSL-2 compliance required; BSL-3 as dictated by specific pathogens.Certified by local/national regulatory bodies; documented safety audits.
Nucleic Acid Extraction Efficiency≥ 80% recovery of target nucleic acid from various sample types.Performance data from method validation studies; consistent results from QC samples.
RT-PCR Limit of Detection (LoD)As per assay manufacturer's specifications or regulatory requirements (e.g., <100 copies/mL).Demonstrated during assay validation and confirmed by ongoing EQA performance.
Assay Specificity≥ 99% specificity for target analytes, with no cross-reactivity with common interfering substances.Results from inclusivity and exclusivity testing during validation.
Equipment Calibration FrequencyAs per manufacturer's recommendations and regulatory guidelines (e.g., annually for PCR, semi-annually for centrifuges).Documented calibration records and certificates.
LIMS Data Integrity100% accuracy in sample tracking, test ordering, and result reporting.Regular internal audits of LIMS data; successful validation of LIMS functionality.

Key Technical Deliverables and Standard Specifications

  • {"items":["Compliance with relevant biosafety standards (e.g., BSL-2, BSL-3 as applicable).","Adequate space allocation for sample reception, processing, amplification, detection, and data analysis.","Segregated workflow design to prevent cross-contamination.","Appropriate ventilation, temperature, and humidity control systems.","Reliable power supply with backup generator and uninterruptible power supply (UPS) for critical equipment.","Secure storage facilities for reagents, samples, and consumables."],"title":"Laboratory Infrastructure and Design"}
  • {"items":["Automated nucleic acid extraction systems (e.g., magnetic bead-based, silica column-based).","Real-time Polymerase Chain Reaction (RT-PCR) instruments (e.g., thermal cyclers with fluorescence detection).","Digital PCR (dPCR) systems for absolute quantification (if applicable).","Automated liquid handling systems for high-throughput sample preparation.","Biosafety cabinets (Class II or III as required).","Centrifuges (refrigerated and non-refrigerated).","Incubators and water baths.","Microscopes (if applicable for sample verification).","Barcode scanners and label printers.","Secure data storage servers and workstations.","Laminar flow hoods."],"title":"Equipment and Instrumentation"}
  • {"items":["Certified and validated nucleic acid extraction kits.","High-quality PCR/RT-PCR reagents, including polymerases, dNTPs, buffers, and primers/probes.","Validated internal controls and positive/negative controls for each assay.","Sterile, nuclease-free consumables (e.g., tubes, plates, pipette tips).","Certified DNA/RNA-free water.","Appropriate disinfectants and cleaning agents."],"title":"Reagents and Consumables"}
  • {"items":["Standardized protocols for sample collection, transportation, and storage.","Validated nucleic acid extraction protocols optimized for different sample types (e.g., blood, saliva, swabs, tissue).","Validated PCR/RT-PCR assay protocols for target analytes (e.g., infectious diseases, genetic mutations, gene expression).","Establishment of assay performance characteristics: sensitivity, specificity, limit of detection (LoD), limit of quantification (LoQ), accuracy, precision, and linearity.","External quality assessment (EQA) participation for all performed assays.","Method validation according to CLIA, CAP, or equivalent regulatory guidelines.","Implementation of universal precautions and strict adherence to biosafety protocols during all testing procedures."],"title":"Testing Methodologies and Validation"}
  • {"items":["Development and implementation of a comprehensive QA/QC program.","Regular calibration and maintenance schedules for all laboratory equipment.","Daily QC checks of reagents and equipment performance.","Internal QC procedures including run controls, calibrators, and proficiency testing.","External QC through EQA programs.","Documentation of all QC results and corrective actions.","Regular training and competency assessment of laboratory personnel.","Standard Operating Procedures (SOPs) for all laboratory activities.","Document control system for SOPs, forms, and records."],"title":"Quality Assurance and Quality Control (QA/QC)"}
  • {"items":["Implementation of a Laboratory Information Management System (LIMS) for sample tracking, data entry, and result generation.","Secure and compliant data storage with regular backups.","Automated result reporting with clear interpretation of findings.","Integration with Electronic Health Records (EHR) or Picture Archiving and Communication Systems (PACS) as required.","Adherence to data privacy regulations (e.g., HIPAA, GDPR).","Standardized report format including patient demographics, test performed, results, interpretation, and clinician information.","Audit trails for all data entries and modifications."],"title":"Data Management and Reporting"}
  • {"items":["Qualified and experienced laboratory director and technical staff.","Ongoing training programs for new techniques, equipment, and safety procedures.","Competency assessments for all laboratory personnel.","Clear job descriptions and responsibilities for each role."],"title":"Personnel and Training"}

Service Level Agreement For Molecular Diagnostics Labs

This Service Level Agreement (SLA) outlines the performance expectations and guarantees for molecular diagnostics laboratory services. It defines the agreed-upon response times for critical services and the uptime guarantees for essential systems. This SLA aims to ensure reliable and timely delivery of diagnostic results, critical for patient care and research.

Service ComponentResponse Time Target (Business Hours)Uptime GuaranteePerformance MetricRemedy for Non-Compliance
Sample Reception and Initial Log-inWithin 4 Business Hours of ArrivalN/APercentage of samples logged within target timeCredit of 5% of monthly service fee for each instance of failure
Critical Assay TAT (e.g., STAT tests, pathogen detection)Within 24 Business Hours of sample log-inN/APercentage of critical assays completed within TATCredit of 10% of monthly service fee for each instance of failure
Routine Assay TATWithin 72 Business Hours of sample log-inN/APercentage of routine assays completed within TATCredit of 5% of monthly service fee for each instance of failure
Laboratory Information System (LIS)N/A99.5% Uptime (excluding scheduled maintenance)Monthly System Uptime PercentageCredit of 10% of monthly LIS service fee for every 2 hours of unplanned downtime beyond agreed limits
Next-Generation Sequencing (NGS) PlatformN/A99.0% Uptime (excluding scheduled maintenance)Monthly Platform Uptime PercentageCredit of 15% of monthly platform service fee for every 2 hours of unplanned downtime beyond agreed limits
Reporting and Data Delivery (via secure portal)Within 2 Business Hours of result availabilityN/APercentage of reports delivered within target timeCredit of 5% of monthly reporting fee for each instance of failure
Technical Support (for system issues)Acknowledged within 1 Business Hour; Resolution Target: 4 Business Hours (for critical issues)N/AAverage response and resolution timesWaived fee for the affected service or a percentage discount on the next invoice, determined by severity

Key Service Components

  • Sample Reception and Processing
  • Assay Turnaround Time (TAT)
  • System Uptime
  • Reporting and Data Delivery
  • Technical Support
In-Depth Guidance

Frequently Asked Questions

Background
Phase 02: Execution

Ready when you are

Let's scope your Molecular Diagnostics Labs in Congo (Brazzaville) project in Congo (Brazzaville).

Speak to Sales